a, Thymic lymphoma-free survival of pI-pC treated Mx-Cre⁺ mice and controls representing combined genotypes including: Mx-Cre⁺;FoxO1^L/L (n=11), Mx-Cre⁺;FoxO1/3^L/L (n=14), Mx-Cre⁺;FoxO1/4^L/L (n=11), and all Mx-Cre⁻ controls (n=36). No lymphomas were observed in controls up to 100 weeks of age. b, Histology and tissue infiltration of thymic lymphoma in Mx-Cre⁺ mouse, H&E stains. (i) thymus (ii) liver, (iii) lung, and (iv) bone marrow. Scale bars: 200 μm (i and ii) and 100 μm (iii and iv). c, FoxO1, FoxO3, and FoxO4 gene deletions in thymic lymphomas and control thymi by PCR analysis. d, Reduction of mRNA levels of FoxO1, FoxO3, and FoxO4 in Mx-Cre⁺ endothelial cells. Quantitative real-time PCR performed on Mx-Cre⁻ thymi (7 weeks), Mx-Cre⁺ thymi (7 weeks), and Mx-Cre⁺ thymic lymphomas (n=2, 19 and 30 weeks post pI-pC); relative reduction of FoxO levels relative to Mx-Cre⁻ thymi is shown. e, Western blot analysis of Mx-Cre⁻ and Mx-Cre⁺ thymi and thymic lymphoma samples. f, Flow cytometric analysis of representative thymic lymphoma.

a, Survival of Mx-Cre⁺ and Mx-Cre⁻ littermates controls. Blue squares indicate deaths due to thymic lymphomas. P value indicates comparison between Mx-Cre⁺ mice (red) and all Mx-Cre⁻ controls (black). b, Age-dependent progression of uterine vascular lesions in Mx-Cre⁺ females, scale Bar=5 mm. c, Histology of systemic vascular lesions, H&E stains. Genotypes are Mx-Cre⁺ unless otherwise noted. i, uterus, low magnification (asterisk: uterine lumen); ii, uterine hemangioma (inset: benign endothelium of hemangioma vascular channels; arrow: endothelial cell); iii, abdominal muscle hemangioma; iv, liver hemangioma, Mx-Cre⁺ mouse; v-vi, angiosarcoma, Mx-Cre⁺ mouse. Scale bars: 500 μm (i and v), 400 μm (iv), 200 μm (iii), and 50 μm (ii and vi). d, Fluorescence micrographs of abdominal muscle, uterine horn, and lung endothelium after vascular perfusion of fluorescein-labeled lectin (blue: DAPI labelled nuclei). Note increased endothelial cell density by 7 weeks in muscle and uterine horn but not in lung as late as 31 weeks. Scale bar=50 μm.

a, Increased proliferation and defective induction of apoptosis in Mx-Cre⁺ thymocytes. Thymocytes from 8-week old mice (n=3 per genotype) were plated and the indicated mitogens or apoptotic stimuli were applied. Experiment was performed twice with similar results; data from a representative experiment is shown. Survival % was calculated after 18hrs of treatment (5 Gy: γ-irradiation; Dex: 1 μM Dexamethasone). b, Analysis of viability of endothelial cells. MTT assays were performed on Mx-Cre⁻ and Mx-Cre⁺ lung (n=2) and liver (n=3) ECs. Y axis, normalized response (%) per OD595. Results represent two independent experiments. For a and b, data are mean ± SEM.

a, Multiple conserved FoxO binding sites (predicted) in vicinity of Sprouty2 gene; ~11kb of the genomic region is shown. 5 of 10 sites were conserved in >3 species including human and mouse (supplementary methods). Sites were scored by 10-based logarithm of the likelihood ratio between the FoxO and background models. b. The FoxO BE occupancy by FoxOs. Soluble chromatin was prepared from Mx-Cre⁻ and Mx- Cre⁺ liver ECs and immunoprecipitated with a mixture of antibodies against the 3 FoxOs. Anti-pol II and anti-FoxO immunoprecipitated DNA (FoxO) was amplified giving rise to ~110bp products (a-d, illustrated in panel a). c, Quantitative real-time PCR analysis for Sprouty2. Expression of Sprouty2 is tightly correlated with FoxO deletion (Mx-Cre⁺) in liver ECs but not in lung ECs (**, p<0.01); error bars = s.e. d. Immunoblot analysis for Sprouty2. Expression of Sprouty2 is lower in FoxO deletion (Mx-Cre⁺) in liver ECs but not in lung ECs compared with control ECs. Duplicate loading shown for each EC line. e. RNA in situ hybridization using antisense Sprouty2 probe tissues from Mx-Cre⁻ and Mx-Cre⁺ mice 3 weeks after pI-pC injection. Arrows point to EC with strong Sprouty2 expression (bar=20μm).

a, Growth advantage of Mx-Cre⁺over Mx-Cre⁻ liver ECs after 10 days culture. Sprouty2 knockdown in Mx-Cre⁻ liver ECs had similar effect. Bar=15μm. b, TUNEL and BrdU. Knockdown of Sprouty2 (shSpry2_1 &_2, shRNAs) in Mx-Cre⁻ liver ECs phenocopies cell growth and apoptosis phenotypes in Mx-Cre⁺ liver ECs; * indicates p<0.01; error bars represent ± s.e. c, knock-down of endogenous Sprouty2 protein expression in Mx-Cre⁻ liver ECs by shSpry2. Two independent replicates are shown. Band densities were measured by ImageJ and normalized to tubulin. Ratio indicates normalized values over that of control (vector infected Mx-Cre⁻ EC). d, Correlation of Sprouty2 expression with cyclinD1, p21, p15, Bim level in liver ECs by quantitative PCR analysis. Knockdown of Sprouty2 with two different shRNAs (shSpry2_1 &_2) recapitulates above differences for cyclinD1, p21, p15, and Bim relative to parental untreated and vector-only controls (lower panels). Results shown are from triplicate experiments; error bars represent ± s.e. e, VEGF-induced tube formation in liver ECs. Bar=100 μm. Average tubule length/HPF (±s.d.) measured by ImageJ software in multiple microscopic fields was plotted (*, p<0.01 versus vector infected Mx-Cre⁻ EC).